In the easypod adherence GH-naïve subgroup, adherence was >90.0% for patients with GHD, irrespective of the cause: idiopathic isolated GHD (92.3%), organic GHD of congenital origin (91.1%) or tumour origin (96.4%). This evidence concerns the gene GH1 and neoplasm.